Olema Pharmaceuticals, Inc. — Director's Dealing 2021

Mar 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Olema Pharmaceuticals, Inc. (OLMA)
CIK: 0001750284
Period of Report: 2021-03-15

Reporting Person: Horn Kinney (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$45.63	A	40000	Acquired	2031-03-14	Common Stock (40000)	Direct

Footnotes

F1: 25% of the shares subject to the option vest on March 15, 2022 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.